To date, the efficacy of PTD fusion proteins, including the anti-apoptotic protein Bcl-xL, neurotrophic factor GDNF, and antioxidant enzyme SOD, have been demonstrated in rodent models of cerebral ischemia [22], [23], [24], [25]. This evidence concerns the gene BCL2L1 and Cerebral ischemia.